Main Targets of Interest for the Development of a Prophylactic or Therapeutic Epstein-Barr Virus Vaccine

Epstein-Barr virus (EBV) is one of the most widespread viruses in the world; more than 90% of the planet’s adult population is infected. Symptomatic primary infection by this Herpesviridae corresponds to infectious mononucleosis (IM), which is generally a benign disease. While virus persistence is o...

Descripción completa

Detalles Bibliográficos
Autores principales: Jean-Pierre, Vincent, Lupo, Julien, Buisson, Marlyse, Morand, Patrice, Germi, Raphaële
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258399/
https://www.ncbi.nlm.nih.gov/pubmed/34239514
http://dx.doi.org/10.3389/fmicb.2021.701611

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8258399/
https://www.ncbi.nlm.nih.gov/pubmed/34239514
http://dx.doi.org/10.3389/fmicb.2021.701611

Ejemplares similares